Calendar NervGen Pharma Corp.

Equities

NGEN

CA64082X2032

Market Closed - Toronto S.E. 03:59:59 2024-06-10 pm EDT 5-day change 1st Jan Change
2.36 CAD +18.00% Intraday chart for NervGen Pharma Corp. +23.56% -12.59%

Chart calendar NervGen Pharma Corp.

38.gdqD1Lx0XcXYe5-aVdZ9u75LkwFecLVKeByz-46tUiQ.1pn77cUhNqypE_LMOp8WltJ-23I4QdgQS3Hst9fvFh3PmLuG0TETk74i8A~ddd0573f1e43931bb56533bede22a9bd

Upcoming events on NervGen Pharma Corp.

2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-04-29 Q4 2024 Earnings Release (Projected)
2025-05-14 Q1 2025 Earnings Release (Projected)

Past events on NervGen Pharma Corp.

2024-06-04 04:00 pm Annual General Meeting
2024-05-16 08:03 am Q1 2024 Earnings Release
2024-04-17 08:32 am Q4 2023 Earnings Release
2023-11-09 08:30 am Q3 2023 Earnings Release
2023-09-14 10:10 am International Spinal Research Trust Network Meeting
2023-09-13 04:00 pm H.C. Wainwright Global Investment Conference
2023-09-11 Investor Meeting
2023-08-24 11:00 am Investor Meeting - Key Opinion Leader
2023-08-09 08:30 am Q2 2023 Earnings Release
2023-06-22 11:30 am OTC Life Science Investor Forum
2023-05-17 04:00 pm Annual General Meeting
2023-05-15 08:01 am Q1 2023 Earnings Release
2023-04-16 American Spinal Injury Association Scientific Meeting
2023-03-30 08:30 am Q4 2022 Earnings Release
2022-11-14 08:03 am Q3 2022 Earnings Release
2022-10-25 European Committee for Treatment and Research in Multiple Sclerosis Congress
2022-10-21 American Neurological Association Meeting
2022-09-28 01:00 pm Annual General Meeting
2022-09-16 International Spinal Cord Society Scientific Meeting
2022-09-11 Military Health System Research Symposium

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million CAD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00



0,00

EBITDA
Million CAD
Released
Forecast
Spread
0,00


-8,75
-9,90
11.59%
-20,1
-19,0
-5.97%
-11,6



-21,6

EBIT
Million CAD
Released
Forecast
Spread
0,00


-12,8
-11,6
-10.92%
-23,0
-24,7
6.78%
0,00



0,00

Earnings before Tax (EBT)
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00



0,00

Net income
Million CAD
Released
Forecast
Spread
-11,2


0,00
0,00
-
0,00
0,00
-
0,00



0,00

EPS
CAD
Released
Forecast
Spread
-0,35


0,00
0,00
-
0,00
0,00
-
0,00



0,00

Announcement Date08/04/2128/02/2230/03/2317/04/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million CAD
Released
Forecast
Spread



0,00
0,00
-
0,00
0,00
-
0,00
0,00
-












EBITDA
Million CAD
Released
Forecast
Spread
-4,20
-2,60
-61.38%
-5,45
-4,00
-36.19%
-4,28
-5,70
24.92%
-6,21
-5,10
-21.81%
-3,78
-4,50
16%

-6,20


-5,60


-5,30

EBIT
Million CAD
Released
Forecast
Spread
-5,00
-3,60
-39.01%
-6,31
-5,00
-26.26%
-4,92
-6,80
27.59%
-6,78
-6,20
-9.42%












Announcement Date12/05/2210/08/2214/11/2230/03/2316/05/24---

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

  1. Stock Market
  2. Equities
  3. NGEN Stock
  4. Calendar NervGen Pharma Corp.